Interferon‐α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus‐related hepatocellular carcinoma

Abstract

IFN-α therapy after curative resection prevented early recurrence and improved overall survival of patients with HBV-related HCC.